L02BA Anti-estrogens

PheWeb

RX_L02BA

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC L02BA

4533

Check pre-conditions, main-only, mode, ICD version None

3709

Check minimum number of events

Min. number of events 3

3709

Include endpoints None

3709

RX_L02BA

Extra metadata

First used in FinnGen datafreeze DF3

Similar endpoints

↥

List of similar endpoints to L02BA Anti-estrogens based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	3602	3534	68
Unadjusted prevalence (%)	1.17	2.04	0.05
Mean age at first event (years)	56.72	56.63	61.53

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.05	4.37 [2.88, 6.64]	4.9e-12	348
15 years	0.02	2.88 [2.01, 4.13]	9.8e-9	167
5 years	0.01	7.11 [5.27, 9.59]	7.0e-38	127
1 year	0.00	7.90 [5.06, 12.35]	1.2e-19	27

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L02BA – L02BA Anti-estrogens
GWS hits:

Survival analyses between endpoints

↥

Plot

before L02BA Anti-estrogens
after L02BA Anti-estrogens

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after L02BA Anti-estrogens

↥